You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. New hurdle seen to prostate screening: primary-care docs
- 2. Orthocell's Remplir used in nerve-sparing prostate cancer surgery
- 3. Machine learning-based analysis identifies glucose metabolism-related genes ADPGK as potential diagnostic biomarkers for clear cell renal cell carcinoma
- 4. Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS‑8 for Prostate Cancer Prevention
- 5. Anti-lipolysis-stimulated lipoprotein receptor antibody-drug conjugate to treat triple-negative breast cancer
- 6. Editorial: Oxidative stress in breast cancer
- 7. Predicting molecular subtype in breast cancer using deep learning on mammography images
- 8. Why more women get cancer in India - but more men die
- 9. Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
- 10. 3D-printed biopolymer-based microneedle for enhanced photodynamic therapy in melanoma treatment
Last updated at 23:02 GMT
Hot News Makers
Health/Pharma Companies
-
79032.92
-
22711.51
-
16612.38
-
9677.87
-
7681.38
-
6531.39
-
6045.90
-
5744.24
-
5402.93
-
4411.68
Drugs, Treatments, Trials
-
94670.79
-
70946.76
-
21461.02
-
12238.14
-
4791.01
-
4584.13
-
3946.14
-
3888.53
-
3707.80
-
3312.38
Last updated at 22:10 GMT
